August 2026 | Edited by: Lena Rivas | | |
The UCSF Center for Infectious Disease Molecular Imaging (CIDMI) continues to establish itself as a leading interdisciplinary hub advancing translational research at the intersection of infectious diseases and molecular imaging. With support from the Division of Experimental Medicine (DEM), the Department of Medicine (DOM), and the Department of Radiology, the Center has successfully expanded its research community, fostered cross-campus collaborations, and demonstrated early scientific impact through strategic pilot funding and educational programming.
Key Accomplishments
- Expanded interdisciplinary collaboration by growing CIDMI membership and creating new opportunities for faculty, trainees, and research partners to engage through seminars, networking, and collaborative initiatives.
- Established a successful Seed Grant Program, awarding 6 pilot grants across two funding cycles (Fall 2025 and Spring 2026), including awards to Dr. Alex Mohapatra and Dr. Joy Okoro (DEM).
- Demonstrated strong return on investment through pilot funding:
- CIDMI-supported investigators secured multiple external awards leveraging Center-supported research.
- Tim and Henry secured grants, with projects leveraging CIDMI infrastructure and collaborations
- Strengthened scientific exchange by hosting seven distinguished seminar speakers over the past year, covering advances in infectious disease imaging, tuberculosis immunity, fungal and bacterial diagnostics, PET tracer development, susceptibility MRI, and spatial multiomics.
- Enhanced research visibility and community engagement through the launch of the CIDMI website and the monthly CIDMI Snapshot newsletter, providing updates on research, funding opportunities, and member accomplishments.
- Improved institutional coordination by establishing regular interdisciplinary meetings that have accelerated collaboration, facilitated resource sharing, and strengthened translational research efforts across UCSF.
- Validated the value of early-stage investment, with initial seed funding generating critical preliminary data that has translated into competitive external funding and positioned CIDMI for sustained scientific impact.
Looking Ahead
CIDMI's early successes demonstrate the importance of continued institutional investment in collaborative infrastructure, pilot funding, and interdisciplinary programming. Sustained support will enable the Center to expand its research portfolio, attract additional external funding, and further strengthen UCSF's leadership in infectious disease molecular imaging and translational science.
Congratulations, CIDMI, on your first year being funded! 🎉
| | |
Suliman Lab
- Celeste Garza, PhD candidate from the Suliman lab, received the Notice of Award for her Ruth L. Kirschstein F31 Predoctoral Fellowship to study the transcriptional regulation of the CD1 antigen-presenting molecules in monocyte-derived Dendritic Cells (DCs). Congratulations, Celeste!
-
Ariana Cardenas, Assistant Specialist in the Suliman lab was awarded a highly competitive Canada Impact+ Research Training Award for international predoctoral trainees: https://sshrc-crsh.canada.ca/en/funding/opportunities/canada-impact-plus-research-training-awards.aspx. Ariana will be starting her PhD in the Department of Immunology, University of Toronto in September. Congratulations, Ariana!
| |
|
Happy Birthday, Amanda & Suchaya!
Thank you for bringing such great energy and positivity to the team every day.
Cheers to another great year ahead. 🎂
| | |
QOL Committee
The Quality of Life Committee (QOL) hosts monthly gatherings.
📅 Stay tuned for the next one!
If you have any questions or would like to join QoL, please contact the QOL Committee.
| | |
 
UCSF Division of Experimental Medicine | Website
| | | | |